đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of the study is to determine the best treatment approach based ...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-08
Trial ID
NCT07624513
The purpose of this study is to measure the efficacy of AZD0120 compared wi...
Status
Not Yet Recruiting
Location
Research Site
Start Date
2026-08-25
Trial ID
NCT07735637
Treatments Being Tested
Based on the need to improve outcomes post second autologous stem cell tran...
Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute (Sarah Cannon)
Start Date
2017-11-22
Trial ID
NCT03030261
Treatments Being Tested
This is a Phase 2 single arm study to evaluate efficacy and safety of Pembr...
Status
Recruiting
Location
Masonic Cancer Center
Start Date
2024-12-04
Trial ID
NCT06377540
Treatments Being Tested
Trial in patients with newly diagnosed myeloma to evaluate the effect of is...
Status
Active Not Recruiting
Location
Uniklinik RWTH Aachen, Klinik fĂŒr HĂ€matologie, Onkologie, HĂ€mostaseologie und Stammzelltransplantation
Start Date
2018-10-18
Trial ID
NCT03617731
Treatments Being Tested
The purpose of this study is to show if addition of Rituximab to intensive ...
Status
Completed
Location
University Hospital Brno-Bohunice
Start Date
2002-05
Trial ID
NCT00558220
The proposed study is a prospective, single-center, single-arm and open-end...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2020-07-27
Trial ID
NCT05504603
To explore the safety and efficacy of systemic radiotherapy (TBI) combined ...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2023-06-14
Trial ID
NCT05970198
Treatments Being Tested
This phase I trial studies the side effects and best dose of loncastuximab ...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-04
Trial ID
NCT05228249
To determine whether a combination of four novel agents bortezomib(Velcade)...
Status
Unknown
Location
Queen Elizabeth Hospital
Start Date
2017-09-28
Trial ID
NCT03188172
Treatments Being Tested